NTM Info and Research Inc. – Nontuberculous Mycobacteria

NTM Info & Research
Welcomes Brandon Mitchell
to Board of Directors

View our webinar series and
more educational videos

Join the Phase 3 trial of
CleaR-Mac – RHB-204 for the Treatment
of Pulmonary Mycobacterium Avium Complex Disease CleaR-MAC)

Join Clinical Trial

ARISE/ENCORE
Clinical Trial Program for MAC Lung Disease

NOW AVAILABLE

"INSIGHT" A Patients Perspective

Insight into the lung disease caused by nontuberculous mycobacteria (NTM),
and empowers the patient to participate in his or her own treatment.

AVAILABLE IN VARIOUS LANGUAGES, REQUEST YOUR COPY TODAY.

Nontuberculous Mycobacteria (NTM Disease) | Woman Breathing with Lungs Expanding

A Physician’s Perspective

by Ed Chan, MD

DOWNLOAD

Airway clearance therapy

is an integral part of
daily lung care and respiratory hygiene

LEARN MORE

STAY INFORMED

Click here to sign up for the latest news on NTMir

NEW RESEARCH OPPORTUNITY

Now recruiting participants for an interview
and questionnaire-only research study of NTM MAC lung disease

LEARN MORE

JOIN NOW

BRONCHIECTASIS PATIENTS

SUPPORT FOR NTM &

WHO WE ARE

NTMir advances a broad agenda on behalf of people with nontuberculous mycobacterial (NTM) disease, as well as healthcare providers, researchers….

SUPPORT GROUPS

Whether it’s a local support group, online forums where you can exchange ideas with other patients, or links to other useful resources, you’ve come to the right place.

"INSIGHT" PATIENT PAMPHLET

Print or download our informative “Insight” pamphlet in multiple languages and keep the knowledge you need at your fingertips.

PHYSICIAN REFERRAL LIST

Find experts in the care you need with our Physician Referral List.

TAKE ACTION

We are stronger as a community than we are alone. Your voice added to ours helps us accomplish our mission.

DONATE

We are supported by patients’ actions and donations, industry, and others who care about those with NTM lung disease.

NTMir’s mission is to save and improve lives through research, education, early detection, and improved treatments for people with pulmonary nontuberculous mycobacterial infection (NTM disease).

Estimated cases of NTM in the US in 2020

0.2 %

The rise in the number of NTM cases each year

0.8 million

Antibiotic-resistant infections in the US each year